Global 35.3 billion Growth of Point-Of-Care Testing (POCT) Market SWOT Analysis with Top Key Players Beckman Coulter, BD, Johnson & Johnson, Alere Inc., PTS Diagnostics, Abbott, Siemens, Roche

Point-Of-Care Testing (POCT) market is changing sides and it is affecting all the players and brands involved in the market which in turn is changing the face of In Vitro Diagnostics industry.

The report comprises of all the information needed to Excel in the Point-Of-Care Testing (POCT) market. The report is a comprehensive study on how the conditions will be in the forecast period of 2018-2025. The report explains what market definition, classifications, applications and key trends are as well as teaches how the market is changing in and how will the change affect in terms of sales, import, export and revenue.

To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

Data Bridge Market Research new Insight’s on “Global Point-of-Care Testing (POCT) Market” is projected to reach 38.2 billion by 2024, from USD 18.5 billion in 2016 growing at a CAGR of 9.5% during the forecast period of 2017 to 2024”.

CAGR levels are GROWING and the Point-of-Care Testing (POCT) market changing day by day. The Point-of-Care Testing (POCT) report consists of all the market definition, classifications, segments, applications, engagements and market trends the user needs to know in order to be successful in the Point-of-Care Testing (POCT) market.

Avail 10% Discount on Direct Purchase “Global Point-of-Care Testing Market” Or kindly send the email at sopan.gedam@databridgemarketresearch.com

Geographic Segmentation:

The global point-of-care testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance, in June 2015, Roche launched its Cardiac point-of-care (POC) troponin test for the cobas h 232 system which is available for countries which accept the CE Mark. This product has improved accuracy at low concentrations and it will help in diagnosis of heart attack patients with high mortality risk. The report includes company share data for different geographies including Global, North America, Europe and APAC.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Recent Developments:

The demand for point-of-care testing (POCT) is growing due to the value-shift in healthcare and increasing technological advancements. Also, the rising prevalence of lifestyle and infectious diseases, early detection of diseases, and management of multiple chronic conditions is fueling the growth of the market. Some of the other factors contributing to the growth of the market are Private investments and venture funding, new product development and government support, increasing adoption of POC devices, and miniaturization of devices. On the other hand, factors such as pricing pressure, low reimbursement, and XX are restraining the growth of the market.

Factors such as emerging market, growing patient pool, rising number of partnerships and joint ventures, and rising initiatives by the market players will contribute to the growth of the market in future. Also, the current focus of the companies on the development of devices for diagnosis and treatment of cancer, stroke, and cardiac patients will drive the market in future. To compete with other POCT companies in the future, POCT companies will need to employ a different set of digital strategies and connectivity solutions.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

Companies Analysis

HOFFMANN-LA ROCHE LTD:

Recent Developments:

1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

SIEMENS AG:

Recent Developments:

1. In November 2016, Siemens strengthened its healthcare business through public listing to give more focus and flexibility in pursuing its growth strategy.
2. In June 2016, Siemens opened a new headquarter in Munich to enhance its global presence in this market.

ABBOTT:

Recent Developments:

1. In May 2017, Abbott announced CE Mark approval and its use of the new Rx Insertable Cardiac Monitor (ICM), which is the world’s first smartphone compatible ICM to identify or detect cardiac arrhythmias, including atrial fibrillation (AF), for therapy.
2. In May 2017, Abbott announced the national reimbursement for freestyle Libre in France, providing access to revolutionary technology for people suffering with diabetes. This would help thousands of people to have access to test type 1 and type 2 diabetes.
3. In February 2017, FDA granted the use of Abbott Real Time Zika test product to detect Zika virus in whole blood samples for use of in vitro diagnostic tests during emergencies.

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

Some of the Major Players Operating in this Market are :

• Abbott Laboratories, Inc.
• Roche Diagnostics Limited
• Siemens AG, Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Johnson & Johnson
• Alere Inc.
• Instrumentation Laboratory
• PTS Diagnostics
• Abaxis, Inc.
• Medtronic
• Accriva Diagnostics
• Opti Medical
• Sienco, Inc.
• Alpha Scientific
• AccuBioTech Co., Ltd.
• ACON Laboratories, Inc.
• Acrongenomics
• BioMérieux
• Biomerica, Inc.
• Atlas Genetics Ltd.
• Alfa Scientific Designs, Inc.
• Bio-Rad Laboratories, Inc.
• Medica Corporation
• Nova Biomedical.

Customization of the Report

• The report includes the complete segmentation displayed above across all above mentioned countries
• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Get 10% Discount on Report @ https://databridgemarketresearch.com/reports/point-care-testing-poct-market/

Related Report

Europe POCT Device Market – Trends and Forecast To 2024

Europe Point-of-care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits), Prescription Mode (Prescription, OTC), Distribution Channel, End User, Country – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/europe-poct-device-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.